{"transactions":[{"id":707515,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-17T21:12:37.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":false,"shares":5220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":2301,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5220},"source":{"system":"sec-edgar","filing":"0000874015-26-000245","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000245/edgardoc.xml","form_type":"4"}},{"id":707514,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T21:12:37.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":true,"shares":5220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":51306,"source":{"system":"sec-edgar","filing":"0000874015-26-000245","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000245/edgardoc.xml","form_type":"4"}},{"id":708532,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-07-16T20:12:08.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment."}],"balance_after":49643,"source":{"system":"sec-edgar","filing":"0000785161-26-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000168/form4.xml","form_type":"4"}},{"id":716465,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-06T22:49:57.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2026 totals no more than $400,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant on July 1, 2026 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant on July 1, 2026 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2026."}],"balance_after":7521,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2301},"source":{"system":"sec-edgar","filing":"0000874015-26-000230","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000230/edgardoc.xml","form_type":"4"}},{"id":716464,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-07-06T22:49:57.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2026 totals no more than $400,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2026 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2026 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2026."}],"balance_after":5369,"derivative":{"exercise_price":79.19,"exercise_date":"2027-07-01","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0000874015-26-000230","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000230/edgardoc.xml","form_type":"4"}},{"id":785823,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-05-11T15:32:52.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":1634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."}],"balance_after":49558,"source":{"system":"sec-edgar","filing":"0000785161-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000134/form4.xml","form_type":"4"}},{"id":807712,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-04-16T18:46:34.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":47924,"source":{"system":"sec-edgar","filing":"0000785161-26-000119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000119/form4.xml","form_type":"4"}},{"id":937931,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-01-16T21:25:52.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":87,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":47839,"source":{"system":"sec-edgar","filing":"0000785161-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000014/form4.xml","form_type":"4"}},{"id":993137,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":false,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":63.9,"exercise_date":"2020-06-10","expiration_date":"2029-06-08","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":993136,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":40.05,"exercise_date":"2022-07-01","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":993135,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":32000,"price":72.1325,"value":2308240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.985 to $72.33 inclusive.  The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4."}],"balance_after":46086,"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":993134,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":true,"shares":32000,"price":63.9,"value":2044800.0,"ownership":{"direct":true},"balance_after":78086,"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":993133,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":72.1325,"value":865590.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.985 to $72.33 inclusive.  The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4."}],"balance_after":46086,"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":993132,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T22:12:11.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":40.05,"value":480600.0,"ownership":{"direct":true},"balance_after":58086,"source":{"system":"sec-edgar","filing":"0000874015-25-000281","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000281/edgardoc.xml","form_type":"4"}},{"id":1018025,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-10-16T19:42:51.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":73,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2025, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $123.65. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":47752,"source":{"system":"sec-edgar","filing":"0000785161-25-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000106/form4.xml","form_type":"4"}},{"id":1085970,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-17T20:54:08.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":5220,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0000874015-25-000158","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000158/edgardoc.xml","form_type":"4"}},{"id":1085969,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-17T20:54:08.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":true,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":46086,"source":{"system":"sec-edgar","filing":"0000874015-25-000158","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000158/edgardoc.xml","form_type":"4"}},{"id":1087037,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-07-16T18:10:32.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":74,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":47679,"source":{"system":"sec-edgar","filing":"0001127602-25-019247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225019247/form4.xml","form_type":"4"}},{"id":1096726,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-02T20:53:09.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":5220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant on July 1, 2025 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant on July 1, 2025 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2025."}],"balance_after":9299,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5220},"source":{"system":"sec-edgar","filing":"0000874015-25-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000139/edgardoc.xml","form_type":"4"}},{"id":1096725,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-07-02T20:53:09.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":11518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2025 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2025 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2025."}],"balance_after":11518,"derivative":{"exercise_price":39.94,"exercise_date":"2026-07-01","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":11518},"source":{"system":"sec-edgar","filing":"0000874015-25-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000139/edgardoc.xml","form_type":"4"}},{"id":1161935,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-05-02T18:34:43.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":47605,"source":{"system":"sec-edgar","filing":"0001127602-25-013136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225013136/form4.xml","form_type":"4"}},{"id":1171358,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-04-16T20:58:59.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $102.30. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":46181,"source":{"system":"sec-edgar","filing":"0001127602-25-012158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225012158/form4.xml","form_type":"4"}},{"id":1301085,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-01-17T19:47:24.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":83,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $93.61. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":46105,"source":{"system":"sec-edgar","filing":"0001127602-25-001402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225001402/form4.xml","form_type":"4"}},{"id":1385429,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-10-17T17:07:47.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":46022,"source":{"system":"sec-edgar","filing":"0001127602-24-025657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224025657/form4.xml","form_type":"4"}},{"id":1453177,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-17T21:02:41.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":false,"shares":4677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":4079,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4677},"source":{"system":"sec-edgar","filing":"0000874015-24-000179","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000179/edgardoc.xml","form_type":"4"}},{"id":1453176,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T21:02:41.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":true,"shares":4677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":42007,"source":{"system":"sec-edgar","filing":"0000874015-24-000179","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000179/edgardoc.xml","form_type":"4"}},{"id":1453283,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-07-17T20:05:36.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $85.49. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":45941,"source":{"system":"sec-edgar","filing":"0001127602-24-020552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224020552/form4.xml","form_type":"4"}},{"id":1461385,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-03T18:47:21.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2024 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant on July 1, 2024 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant on July 1, 2024 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2024."}],"balance_after":8756,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0000874015-24-000162","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000162/edgardoc.xml","form_type":"4"}},{"id":1461384,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-03T18:47:21.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":10111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2024 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2024 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2024 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2024."}],"balance_after":10111,"derivative":{"exercise_price":47.11,"exercise_date":"2025-07-01","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":10111},"source":{"system":"sec-edgar","filing":"0000874015-24-000162","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000162/edgardoc.xml","form_type":"4"}},{"id":1529667,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-05-03T17:09:03.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":1978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":45861,"source":{"system":"sec-edgar","filing":"0001127602-24-014070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224014070/form4.xml","form_type":"4"}},{"id":1541634,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-04-16T20:45:28.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment"}],"balance_after":43883,"source":{"system":"sec-edgar","filing":"0001127602-24-013008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224013008/form4.xml","form_type":"4"}},{"id":1678697,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-01-17T21:10:00.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":91,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":43803,"source":{"system":"sec-edgar","filing":"0001127602-24-001413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224001413/form4.xml","form_type":"4"}},{"id":1759481,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-10-17T21:17:36.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":43712,"source":{"system":"sec-edgar","filing":"0001127602-23-026013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223026013/form4.xml","form_type":"4"}},{"id":1827341,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-07-19T22:05:48.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":4677,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-23-000175","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000175/edgardoc.xml","form_type":"4"}},{"id":1827340,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-07-19T22:05:48.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":10010,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1777},"source":{"system":"sec-edgar","filing":"0000874015-23-000175","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000175/edgardoc.xml","form_type":"4"}},{"id":1827339,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T22:05:48.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":37330,"source":{"system":"sec-edgar","filing":"0000874015-23-000175","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000175/edgardoc.xml","form_type":"4"}},{"id":1827338,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T22:05:48.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":31997,"source":{"system":"sec-edgar","filing":"0000874015-23-000175","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000175/edgardoc.xml","form_type":"4"}},{"id":1828278,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-07-18T17:51:26.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":95,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":43611,"source":{"system":"sec-edgar","filing":"0001127602-23-020905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223020905/form4.xml","form_type":"4"}},{"id":1834556,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-07-06T21:14:21.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":4677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2023 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant on July 3, 2023 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant on July 3, 2023 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 3, 2023."}],"balance_after":11787,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4677},"source":{"system":"sec-edgar","filing":"0000874015-23-000157","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000157/edgardoc.xml","form_type":"4"}},{"id":1834555,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-06T21:14:21.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":10321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2023 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 3, 2023 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 3, 2023 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 3, 2023."}],"balance_after":10321,"derivative":{"exercise_price":41.08,"exercise_date":"2024-07-03","expiration_date":"2033-07-02","underlying":"Common Stock","underlying_shares":10321},"source":{"system":"sec-edgar","filing":"0000874015-23-000157","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000157/edgardoc.xml","form_type":"4"}},{"id":1856539,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-14T20:50:22.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":false,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":7110,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3555},"source":{"system":"sec-edgar","filing":"0000874015-23-000142","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000142/edgardoc.xml","form_type":"4"}},{"id":1856538,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T20:50:22.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":true,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":30220,"source":{"system":"sec-edgar","filing":"0000874015-23-000142","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000142/edgardoc.xml","form_type":"4"}},{"id":1901695,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-05-08T17:08:36.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":43516,"source":{"system":"sec-edgar","filing":"0001127602-23-014819","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223014819/form4.xml","form_type":"4"}},{"id":1917651,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-04-19T17:19:04.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":41131,"source":{"system":"sec-edgar","filing":"0001127602-23-013208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223013208/form4.xml","form_type":"4"}},{"id":2051680,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-01-19T16:39:06.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":41032,"source":{"system":"sec-edgar","filing":"0001127602-23-001739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223001739/form4.xml","form_type":"4"}},{"id":2135150,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-10-19T15:04:57.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":40933,"source":{"system":"sec-edgar","filing":"0001127602-22-024114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222024114/form4.xml","form_type":"4"}},{"id":2204221,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-07-21T20:58:22.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":34093,"source":{"system":"sec-edgar","filing":"0001127602-22-019595","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222019595/form4.xml","form_type":"4"}},{"id":2205789,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-19T23:20:46.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":1777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":10665,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1777},"source":{"system":"sec-edgar","filing":"0000874015-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000139/edgardoc.xml","form_type":"4"}},{"id":2205788,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-19T23:20:46.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":12442,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000139/edgardoc.xml","form_type":"4"}},{"id":2205787,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T23:20:46.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":1777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":26665,"source":{"system":"sec-edgar","filing":"0000874015-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000139/edgardoc.xml","form_type":"4"}},{"id":2205786,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T23:20:46.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":24888,"source":{"system":"sec-edgar","filing":"0000874015-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000139/edgardoc.xml","form_type":"4"}},{"id":2213216,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-06T21:25:13.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022."}],"balance_after":17775,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000121/edgardoc.xml","form_type":"4"}},{"id":2213215,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-07-06T21:25:13.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022."}],"balance_after":12000,"derivative":{"exercise_price":38.06,"exercise_date":"2023-07-01","expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000874015-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000121/edgardoc.xml","form_type":"4"}},{"id":2233338,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-14T22:03:55.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis."}],"balance_after":12442,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3555},"source":{"system":"sec-edgar","filing":"0000874015-22-000108","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000108/edgardoc.xml","form_type":"4"}},{"id":2233337,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T22:03:55.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":19555,"source":{"system":"sec-edgar","filing":"0000874015-22-000108","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401522000108/edgardoc.xml","form_type":"4"}},{"id":2278534,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-05-09T20:15:44.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":2226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":33867,"source":{"system":"sec-edgar","filing":"0001127602-22-013829","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222013829/form4.xml","form_type":"4"}},{"id":2294305,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-04-20T17:52:27.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":31641,"source":{"system":"sec-edgar","filing":"0001127602-22-012242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222012242/form4.xml","form_type":"4"}},{"id":2431579,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-01-20T22:09:27.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":31520,"source":{"system":"sec-edgar","filing":"0001127602-22-001730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222001730/form4.xml","form_type":"4"}},{"id":2540006,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-10-19T13:30:39.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":31381,"source":{"system":"sec-edgar","filing":"0001127602-21-027253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221027253/form4.xml","form_type":"4"}},{"id":2631126,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-07-20T00:13:48.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":15997,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0000874015-21-000135","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000135/edgardoc.xml","form_type":"4"}},{"id":2631125,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-07-20T00:13:48.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":17775,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-21-000135","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000135/edgardoc.xml","form_type":"4"}},{"id":2631124,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T00:13:48.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0000874015-21-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000135/edgardoc.xml","form_type":"4"}},{"id":2631123,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T00:13:48.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."}],"balance_after":14222,"source":{"system":"sec-edgar","filing":"0000874015-21-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000135/edgardoc.xml","form_type":"4"}},{"id":2632643,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-07-16T18:53:35.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":31255,"source":{"system":"sec-edgar","filing":"0001127602-21-022097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221022097/form4.xml","form_type":"4"}},{"id":2642517,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-07-06T21:51:08.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021."}],"balance_after":23108,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000113/edgardoc.xml","form_type":"4"}},{"id":2642516,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-06T21:51:08.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021."}],"balance_after":12000,"derivative":{"exercise_price":40.05,"exercise_date":"2022-07-01","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000874015-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000113/edgardoc.xml","form_type":"4"}},{"id":2670911,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-14T22:46:13.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":17775,"derivative":{"underlying":"Common Stock","underlying_shares":3555},"source":{"system":"sec-edgar","filing":"0000874015-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000082/edgardoc.xml","form_type":"4"}},{"id":2670910,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T22:46:13.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award."}],"balance_after":8889,"source":{"system":"sec-edgar","filing":"0000874015-21-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401521000082/edgardoc.xml","form_type":"4"}},{"id":2721899,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-05-10T16:12:52.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":1757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":31149,"source":{"system":"sec-edgar","filing":"0001127602-21-015985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221015985/form4.xml","form_type":"4"}},{"id":2746310,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-04-19T13:46:33.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":97,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":29392,"source":{"system":"sec-edgar","filing":"0001127602-21-013954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221013954/form4.xml","form_type":"4"}},{"id":2903584,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-01-20T17:35:59.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":95,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":29295,"source":{"system":"sec-edgar","filing":"0001127602-21-002087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221002087/form4.xml","form_type":"4"}},{"id":3003422,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-10-20T14:37:40.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":29200,"source":{"system":"sec-edgar","filing":"0001127602-20-027245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220027245/form4.xml","form_type":"4"}},{"id":3079837,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-07-20T21:06:50.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":29083,"source":{"system":"sec-edgar","filing":"0001127602-20-021829","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220021829/form4.xml","form_type":"4"}},{"id":3090071,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-07-06T21:51:27.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020."}],"balance_after":12000,"derivative":{"exercise_price":60.2,"exercise_date":"2021-07-01","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000874015-20-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000107/edgar.xml","form_type":"4"}},{"id":3090070,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-06T21:51:27.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on uly 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on uly 1, 2020."}],"balance_after":5333,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0000874015-20-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000107/edgar.xml","form_type":"4"}},{"id":3090069,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-06T21:51:27.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":5332,"derivative":{"underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0000874015-20-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000107/edgar.xml","form_type":"4"}},{"id":3090068,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-06T21:51:27.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards."}],"balance_after":5334,"source":{"system":"sec-edgar","filing":"0000874015-20-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000107/edgar.xml","form_type":"4"}},{"id":3107833,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-06-18T00:15:13.000Z","date":"2020-06-10","kind":"exercise","acquired":false,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":10665,"derivative":{"underlying":"Common Stock","underlying_shares":3556},"source":{"system":"sec-edgar","filing":"0000874015-20-000070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000070/edgar.xml","form_type":"4"}},{"id":3107832,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T00:15:13.000Z","date":"2020-06-10","kind":"exercise","acquired":true,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award"},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award"}],"balance_after":3556,"source":{"system":"sec-edgar","filing":"0000874015-20-000070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401520000070/edgar.xml","form_type":"4"}},{"id":3158780,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-05-07T21:41:21.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":2304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":28962,"source":{"system":"sec-edgar","filing":"0001127602-20-015805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220015805/form4.xml","form_type":"4"}},{"id":3174782,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-04-17T13:14:18.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":26658,"source":{"system":"sec-edgar","filing":"0001127602-20-013956","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220013956/form4.xml","form_type":"4"}},{"id":3306938,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-01-21T14:16:33.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":93,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":26554,"source":{"system":"sec-edgar","filing":"0001127602-20-001992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220001992/form4.xml","form_type":"4"}},{"id":3392531,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-10-17T15:22:35.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":26461,"source":{"system":"sec-edgar","filing":"0001127602-19-030671","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219030671/form4.xml","form_type":"4"}},{"id":3460350,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-07-17T22:11:10.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":26350,"source":{"system":"sec-edgar","filing":"0001127602-19-024797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219024797/form4.xml","form_type":"4"}},{"id":3469503,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-07-03T22:54:40.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019."}],"balance_after":16000,"derivative":{"exercise_price":64.8,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000874015-19-000108","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000108/edgar.xml","form_type":"4"}},{"id":3469502,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-07-03T22:54:40.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019."}],"balance_after":7110,"derivative":{"underlying":"Common Stock","underlying_shares":7110},"source":{"system":"sec-edgar","filing":"0000874015-19-000108","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000108/edgar.xml","form_type":"4"}},{"id":3493343,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-13T00:15:46.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":14221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of June 10, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on June 10, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on June 10, 2023. The RSU is vested as to 0 shares on June 10, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant of June 10, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on June 10, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on June 10, 2023. The RSU is vested as to 0 shares on June 10, 2019."}],"balance_after":14221,"derivative":{"underlying":"Common Stock","underlying_shares":14221},"source":{"system":"sec-edgar","filing":"0000874015-19-000077","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000077/edgar.xml","form_type":"4"}},{"id":3493344,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-12T21:16:39.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of June 10, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on June 10, 2020. The option shall be fully vested and exercisable on June 10, 2023. The option is exercisable to 0 shares on June 10, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grant of June 10, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on June 10, 2020. The option shall be fully vested and exercisable on June 10, 2023. The option is exercisable to 0 shares on June 10, 2019."}],"balance_after":32000,"derivative":{"exercise_price":63.9,"exercise_date":"2020-06-10","expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000874015-19-000075","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000075/edgar.xml","form_type":"4"}},{"id":3537130,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-05-07T16:01:22.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":26243,"source":{"system":"sec-edgar","filing":"0001127602-19-017543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219017543/form4.xml","form_type":"4"}},{"id":3550537,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-04-24T13:09:40.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":23916,"source":{"system":"sec-edgar","filing":"0001127602-19-016097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219016097/form4.xml","form_type":"4"}},{"id":3695023,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-01-16T21:09:33.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":94,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":23814,"source":{"system":"sec-edgar","filing":"0001127602-19-002123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219002123/form4.xml","form_type":"4"}},{"id":3789364,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-10-17T19:59:19.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":83,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":23720,"source":{"system":"sec-edgar","filing":"0001127602-18-030493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218030493/form4.xml","form_type":"4"}},{"id":3793667,"issuer":{"id":163096,"kind":"organization","name":"CONVERGYS CORP","symbol":"CVG"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-10-10T16:24:49.000Z","date":"2018-10-05","kind":"disposition_to_issuer","acquired":false,"shares":33612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, these shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive $445,359 in cash and 4,245.20 shares of SYNNEX Corporation common stock having a market value of $89.14 per share, based on the closing price of SYNNEX common stock on October 5, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-054685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062047/000120919118054685/doc4.xml","form_type":"4"}},{"id":3793666,"issuer":{"id":163096,"kind":"organization","name":"CONVERGYS CORP","symbol":"CVG"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-10-10T16:24:49.000Z","date":"2018-10-05","kind":"disposition_to_issuer","acquired":false,"shares":11923,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the Effective Time (as defined in the Agreement and Plan of Merger, dated June 28, 2018 (as amended, the \"Merger Agreement\"), by and among the Company, SYNNEX Corporation, Delta Merger Sub I, Inc. and Concentrix CVG Corporation), these time-based restricted stock units and deferred stock units were converted into the right to receive $295,213.48 in cash, which amount will vest and be paid in accordance with the Merger Agreement and the applicable award agreements."}],"balance_after":33612,"source":{"system":"sec-edgar","filing":"0001209191-18-054685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062047/000120919118054685/doc4.xml","form_type":"4"}},{"id":3865741,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-07-18T20:04:12.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":83,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":23637,"source":{"system":"sec-edgar","filing":"0001127602-18-023486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218023486/form4.xml","form_type":"4"}},{"id":3931282,"issuer":{"id":163096,"kind":"organization","name":"CONVERGYS CORP","symbol":"CVG"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-05-16T16:29:13.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":5157,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of time-based restricted stock units."}],"balance_after":45535,"source":{"system":"sec-edgar","filing":"0001209191-18-030504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062047/000120919118030504/doc4.xml","form_type":"4"}},{"id":3944893,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-05-07T20:59:56.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":2386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":23554,"source":{"system":"sec-edgar","filing":"0001127602-18-016518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218016518/form4.xml","form_type":"4"}},{"id":3961521,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-04-18T22:25:41.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":89,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21168,"source":{"system":"sec-edgar","filing":"0001127602-18-014890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218014890/form4.xml","form_type":"4"}},{"id":4097197,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-01-18T21:45:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":98,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21079,"source":{"system":"sec-edgar","filing":"0001127602-18-002084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218002084/form4.xml","form_type":"4"}},{"id":4184338,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":29927,"kind":"person","name":"HERMAN JOAN E","position":1,"cik":"0001248398","reported_name":"HERMAN JOAN E","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-10-18T16:00:26.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2017, HealthSouth paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":20981,"source":{"system":"sec-edgar","filing":"0001127602-17-029994","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217029994/form4.xml","form_type":"4"}}],"next_cursor":"2017-10-18T16:00:26.000000Z,4184338"}